Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance - 'Ichnos Glenmark Innovation'
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Stay updated with breaking news from Ichnos Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Glenmark Pharmaceuticals Ltd , a leading, research-driven, global pharmaceutical company, and Ichnos Sciences...
IGI is introducing a pipeline of three oncology molecules currently undergoing clinical trials, targeting multiple myeloma, acute myeloid leukemia, and solid tumors.
Stocks to watch out for today: IRCON International, Maruti Suzuki, Infosys, HCL Tech, RITES, Paytm, Persistent Systems, IDBI Bank, Glenmark Pharmaceuticals, HDFC Asset Management Company, Sun Pharma, Advance Lifestyles and more
With the execution of this agreement, Ichnos has successfully licensed its two assets for inflammatory and immunological diseases, a key milestone in the company's prioritisation of its pipeline of oncology drug candidates, Ichnos Sciences said in a statement filed on BSE by Glenmark.